Literature DB >> 30464147

Valproate-Induced Polycystic Ovary Syndrome in a Girl with Epilepsy: A Case Study.

Yasuhiko Kawakami1,2, Shuichi Fujii2, Gen Ishikawa3, Atsuko Sekiguchi4, Akihito Nakai4, Masato Takase2.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common ovulatory disorder that can be induced by sodium valproate (VPA). PATIENT: We report a case of PCOS that developed in a 15-year-old girl with idiopathic epilepsy after she took VPA. VPA administration stopped her seizures, but it also led to weight gain and amenorrhea, and the patient was diagnosed with PCOS on the basis of diagnostic imaging and serological examination results. Cessation of VPA administration led to reduced weight gain and restored menstruation.
CONCLUSIONS: The risk of PCOS developing in patients with epilepsy is known to be high, and the association of VPA with PCOS is well established, so if physicians feel this is the best drug to prescribe for female patients with epilepsy, they should carefully monitor the patients' weight and menstruation, and immediately perform ovarian imaging and hormonal examinations if any abnormalities are observed.

Entities:  

Keywords:  polycystic ovary syndrome; sodium valproate

Mesh:

Substances:

Year:  2018        PMID: 30464147     DOI: 10.1272/jnms.JNMS.2018_85-46

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  4 in total

1.  Photosensitive Epilepsy and Polycystic Ovary Syndrome as Manifestations of MERRF.

Authors:  Josef Finsterer
Journal:  Case Rep Neurol Med       Date:  2020-09-28

2.  Investigating the molecular mechanism of Compound Danshen Dropping Pills for the treatment of epilepsy by utilizing network pharmacology and molecular docking technology.

Authors:  Dan Huang; Xiaolong Wen; Chuansen Lu; Bo Zhang; Zongjun Fu; Yingliu Huang; Kun Niu; Fan Yang
Journal:  Ann Transl Med       Date:  2022-02

Review 3.  No population left behind: Improving paediatric drug safety using informatics and systems biology.

Authors:  Nicholas P Giangreco; Jonathan E Elias; Nicholas P Tatonetti
Journal:  Br J Clin Pharmacol       Date:  2021-01-19       Impact factor: 3.716

4.  Evaluating risk detection methods to uncover ontogenic-mediated adverse drug effect mechanisms in children.

Authors:  Nicholas P Giangreco; Nicholas P Tatonetti
Journal:  BioData Min       Date:  2021-07-22       Impact factor: 2.522

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.